ResMed Inc. (LON:0KW4)
London · Delayed Price · Currency is GBP · Price in USD 277.94
+3.56 (1.30%)
At close: Oct 3, 2025
ResMed Market Cap
ResMed has a market cap or net worth of 30.16 billion as of October 3, 2025. Its market cap has increased by 13.90% in one year.
Market Cap
30.16B
Enterprise Value
29.90B
Revenue
3.76B
Ranking
n/a
PE Ratio
29.50
Stock Price
277.94
Market Cap Chart
Since June 2, 1995, ResMed's market cap has increased from 24.33M to 30.16B, an increase of 123,864.65%. That is a compound annual growth rate of 26.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 30.16B | 12.45% |
| Dec 31, 2024 | 26.82B | 35.04% |
| Dec 29, 2023 | 19.86B | -21.72% |
| Dec 30, 2022 | 25.37B | -9.78% |
| Dec 31, 2021 | 28.12B | 24.65% |
| Dec 31, 2020 | 22.56B | 34.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.12B |
| GSK plc | 66.29B |
| Haleon | 29.39B |
| Smith & Nephew | 11.59B |
| ConvaTec Group | 4.78B |
| Hikma Pharmaceuticals | 4.06B |
| HUTCHMED (China) | 2.03B |
| Genus | 1.64B |